63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05653349 (ClinicalTrials.gov)	March 31, 2023	23/11/2022	Study of IanalumabVersus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombo ...	A Phase III, Randomized, Double-blind Study of Ianalumab(VAY736) Versus Placebo in Addition to First ...	Primary Immune Thrombocytopenia (ITP)	Biological: Ianalumab;Drug: Placebo;Drug: Corticosteroids	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	225	Phase 3	Belgium;Hungary;Romania;Singapore;Spain;United Kingdom
2	NCT05653219 (ClinicalTrials.gov)	February 2, 2023	23/11/2022	A Study of Efficacy and Safety of IanalumabVersus Placebo in Addition to Eltrombopag in Primary Immu ...	A Phase 3 Randomized, Double-blind Study of Ianalumab(VAY736) Versus Placebo in Addition to Eltrombo ...	Primary Immune Thrombocytopenia	Biological: Ianalumab;Drug: Eltrombopag;Drug: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	150	Phase 3	Czechia;Hungary;Korea, Republic of;Singapore;United Kingdom
3	EUCTR2022-001627-32-ES (EUCTR)	23/01/2023	01/11/2022	A phase 3, randomized, double-blind, study of ianalumab(VAY736) versus placebo in addition to eltrom ...	A phase 3 randomized, double-blind study of ianalumab(VAY736) versus placebo in addition to eltrombo ...	immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: PT;Classification code 10083842;Term: Immu ...	Product Name: Ianalumab Product Code: VAY736 INN or Proposed INN: Ianalumab	Novartis Farmacéutica, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Philippines;Taiwan;Thailand;Spain;Italy;India;France;Malaysia;Australia;Netherlands;Ch ...
4	EUCTR2022-001627-32-NL (EUCTR)	29/12/2022	31/10/2022	A phase 3, randomized, double-blind, study of ianalumab(VAY736) versus placebo in addition to eltrom ...	A phase 3 randomized, double-blind study of ianalumab(VAY736) versus placebo in addition to eltrombo ...	immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: PT;Classification code 10083842;Term: Immu ...	Product Name: Ianalumab Product Code: VAY736 INN or Proposed INN: Ianalumab	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Philippines;Taiwan;Thailand;Spain;Italy;India;France;Malaysia;Australia;Netherlands;Ch ...
5	EUCTR2022-001672-34-ES (EUCTR)	23/12/2022	11/10/2022	A study of ianalumab(VAY736) in addition to first-line corticosteroids in patients with primary immu ...	A phase III, randomized, double-blind study of ianalumab(VAY736) versus placebo in addition to first ...	Primary Immune thrombocytopenia (ITP);Therapeutic area: Diseases [C] - Blood and lymphatic diseases ...	Product Name: Ianalumab Product Code: VAY736 INN or Proposed INN: Ianalumab	Novartis Farmacéutica, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	225	Phase 3	United States;Czechia;Hong Kong;Spain;Thailand;Turkey;Austria;United Kingdom;Italy;India;France;Czec ...
6	EUCTR2022-001627-32-CZ (EUCTR)	05/12/2022	20/10/2022	A phase 3, randomized, double-blind, study of ianalumab(VAY736) versus placebo in addition to eltrom ...	A phase 3 randomized, double-blind study of ianalumab(VAY736) versus placebo in addition to eltrombo ...	immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: PT;Classification code 10083842;Term: Immu ...	Product Name: Ianalumab Product Code: VAY736 INN or Proposed INN: Ianalumab	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	Singapore;United States;Czechia;Malaysia;Thailand;Austria;Netherlands;China;Korea, Republic of;Franc ...

First Previous1Next Last